ArticleJournal of immunology research2022

Serum sPD1 and sPDL1 as Biomarkers for Evaluating the Immune State of Lung Adenocarcinoma Patients.

Yumin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.